Autopsy report · NCT06800183

Topical Tartrazine for Improved Skin Structure Visualization in Dermatology

“The investigators are revisiting in vitro and in vivo studies to ensure the ability to replicate the results of the original paper before proceeding to the pilot clinical study.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Early Phase 1

Sponsor

Johns Hopkins University

Sponsor type

University, hospital or other

Conditions

Healthy; Dermoscopy; Optical Imaging

Interventions

Four-Chamber Tartrazine Patch across 3 Body Sites

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Optimized Caloric-proteic Nutrition in Septic and Septic Shock Patients
  “The protocol was modified substantially and will be resubmitted to Clinical Trial” (57% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.